Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Pideka Group Inc., (formerly known as Ikänik Farms) is multi-national operator with a medical grade indoor cultivation facility and laboratory (Pideka SAS) in Bogata Colombia which holds EU GMP, (GMP-PHARMA) and Good Agricultural and Collection Practice (GACP) certifications. 

Investor Note: In addition to the 168,101,981 Subordinate Voting Shares that are listed and trading, there are 14,935,500 shares reserved specifically for issuance pursuant to the conversion rights attached to the Series A Multiple Voting Shares that are issued and outstanding but not listed.  The total number of equity shares assuming all are converted into the listed class would be 183,037,481.

IMCC is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products. In Europe, IMCC is establishing a fully operational, vertically integrated medical cannabis business spearheaded by its distribution arm in Germany and augmented by strategic agreements with certified EU-GMP Standard suppliers, making it one of the only medical cannabis companies with fully integrated operations in Europe. IMCC intends to leverage IMCC's brand to establish a foothold in emerging medical cannabis markets including Germany, Portugal and Greece.

The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.

IONIC BRANDS Corp. is dedicated to building a regionally based multi-state consumer-focused cannabis concentrate brand portfolio with strong roots in the premium and luxury segments of vape concentrates and edibles. The cornerstone brand of the portfolio, IONIC, is a top vaporizer brand in Washington State along with its economy brand Dabulous and has aggressively expanded throughout the Pacific Northwest of the United States. The brand is currently operating in Washington and Oregon. IONIC BRANDS' strategy is to be the leader of the highest-value segments of the cannabis market.

Each whole Warrant shall entitle each Warrantholder thereof, upon exercise at any time after the issue thereof and prior to the Expiry Time, to acquire one (1) Warrant Share upon payment of the Exercise Price of $0.30.

See the Warrant Indenture for full details.

Irwin Naturals is a nutraceutical company that distributes dietary supplements to more than 100,000 retailers, including mass-market retailers.

Investor Note: In addition to the 3,369,368 Subordinate Voting Shares that are listed and trading, there are (i) 340,300 subordinate voting shares reserved for issuance pursuant to the conversion rights attached to the Proportionate Voting Shares of Irwin Naturals Inc. (ii) 18,240 subordinate voting shares reserved for issuance pursuant to the conversion rights attached to the Multiple Voting Shares of Irwin Naturals Inc.; (iii) 320,000,000 subordinate voting shares reserved for issuance pursuant to the exchange rights attached to the Class B Non-Voting Shares of Irwin Naturals, an indirect, wholly-owned subsidiary of Irwin Naturals Inc.; and (iv) 20,000 subordinate voting share purchase warrants.  The total number of equity shares assuming all are converted or exchanged, as applicable, into the listed class would be 323,747,908.

Isracann Biosciences Inc. is an Israeli-based company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied major European marketplaces. Based in Israel's agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research.

The Company is engaged in the commercialization of proprietary diagnostic products for breast cancer. Its business strategy is to complete the commercial development of 360 degree, true 3D breast imaging technology for early diagnosis of breast cancer. The Company holds a license under a license agreement to make, have made, use, offer for sale, import, and sell products and services and to practice processes and methods in the field of human diagnostics and therapeutics in the United States and any other countries where approvals are granted or where patent rights may exist in the future with respect to certain licensed patent rights.

Jolt Health Inc., is a specialized health and wellness company offering pharmaceutical and therapeutic products with proven technologies for which it has the exclusive rights to produce, package and sell thoughout  Europe, North America and the United Kingdom. Many of the products are market-ready, with proven history of significant sales. The Company is focused on the global sexual wellness and enhancement market. 

Jushi Holdings Inc. is a vertically-integrated, multi state cannabis operator led by an industry leading management team. In the United States Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high quality products across all levels of the cannabis ecosystem.

Contact The Team

How can we help you?

Contact the CSE team to find out more.